| scholarly article | Q13442814 |
| P2093 | author name string | T. D. Wilkins | |
| G. Corthier | |||
| L. A. Barroso | |||
| C. Depitre | |||
| D. M. Lyerly | |||
| P2860 | cites work | Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications | Q24561689 |
| Purification and characterization of toxins A and B of Clostridium difficile | Q24604972 | ||
| Clostridium difficile: its disease and toxins | Q24617347 | ||
| Effects of Clostridium difficile toxins A and B in rabbit small and large intestine in vivo and on cultured cells in vitro | Q24651060 | ||
| Enzyme-linked immunosorbent assay for Clostridium difficile toxin A | Q24652980 | ||
| Molecular characterization of the Clostridium difficile toxin A gene | Q24656092 | ||
| Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
| Detection of specific sequences among DNA fragments separated by gel electrophoresis | Q25939003 | ||
| Sequence from picomole quantities of proteins electroblotted onto polyvinylidene difluoride membranes | Q28131700 | ||
| High efficiency transformation of E. coli by high voltage electroporation | Q29615278 | ||
| Production of Clostridium difficile antitoxin | Q33904565 | ||
| Nucleotide sequence of Clostridium difficile toxin B gene | Q35849070 | ||
| Biological activities of toxins A and B of Clostridium difficile | Q36438279 | ||
| Construction and expression of the complete Clostridium difficile toxin A gene in Escherichia coli | Q36959185 | ||
| Purification and characterization of Clostridium sordellii hemorrhagic toxin and cross-reactivity with Clostridium difficile toxin A (enterotoxin). | Q37004400 | ||
| Characterization of toxins A and B of Clostridium difficile with monoclonal antibodies | Q37011926 | ||
| Monoclonal and specific polyclonal antibodies for immunoassay of Clostridium difficile toxin A | Q37274931 | ||
| Ribosomal DNA spacer-length polymorphisms in barley: mendelian inheritance, chromosomal location, and population dynamics | Q37581058 | ||
| Purification and characterization of Clostridium sordellii lethal toxin and cross-reactivity with Clostridium difficile cytotoxin. | Q40162220 | ||
| Enzyme immunoassays for detection of Clostridium difficile toxins A and B in fecal specimens | Q72417738 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Clostridium difficile | Q310543 |
| bacterial protein | Q64923821 | ||
| P304 | page(s) | 4633-4639 | |
| P577 | publication date | 1992-11-01 | |
| P1433 | published in | Infection and Immunity | Q6029193 |
| P1476 | title | Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile | |
| P478 | volume | 60 |
| Q39554772 | A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. |
| Q26778130 | An Update on Clostridium difficile Toxinotyping |
| Q40478915 | Both, toxin A and toxin B, are important in Clostridium difficile infection. |
| Q33968261 | Characterization of a toxin A-negative, toxin B-positive strain of Clostridium difficile responsible for a nosocomial outbreak of Clostridium difficile-associated diarrhea. |
| Q40638584 | Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping |
| Q74592566 | Clostridium difficile |
| Q34916871 | Clostridium difficile 027/BI/NAP1 encodes a hypertoxic and antigenically variable form of TcdB. |
| Q39590100 | Clostridium difficile infection of the gut |
| Q35062641 | Clostridium difficile testing: after 20 years, still challenging |
| Q24522454 | Clostridium difficile toxins: mechanism of action and role in disease |
| Q91902444 | Controversies in Clostridium difficile testing |
| Q72897696 | Detection of toxigenic Clostridium difficile in fecal samples by colony blot hybridization |
| Q39664638 | Development and evaluation of a PCR method for detection of the Clostridium difficile toxin B gene in stool specimens |
| Q35649605 | Diarrhea recurrence in patients with Clostridium difficile-associated diarrhea: Role of concurrent antibiotics |
| Q42929597 | Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile |
| Q41169559 | Evaluation of two commercial microtiter cytotoxin assays for the detection of Clostridium difficile toxin B in stool specimens |
| Q33712691 | Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens |
| Q50869220 | Evaluation of two rapid immunochromatography tests for the detection of Clostridium difficile toxins. |
| Q39460228 | Genetic characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates by PCR. |
| Q39658215 | High frequency of antibiotic-associated diarrhea due to toxin A-negative, toxin B-positive Clostridium difficile in a hospital in Japan and risk factors for infection |
| Q40110456 | High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection |
| Q74431208 | High prevalence of toxin A-negative toxin B-positive Clostridium difficile in hospitalized patients with gastrointestinal disease |
| Q33674642 | Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. |
| Q39748439 | International typing study of toxin A-negative, toxin B-positive Clostridium difficile variants |
| Q42871087 | Investigation of Toxin Gene Diversity, Molecular Epidemiology, and Antimicrobial Resistance of Clostridium difficile Isolated from 12 Hospitals in South Korea |
| Q34146714 | Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates |
| Q44612565 | Molecular cloning, overexpression in Escherichia coli, and purification of 6×his-tagged C-terminal domain of Clostridium difficile toxins A and B |
| Q36326824 | Molecular epidemiology and antimicrobial susceptibility of Clostridium difficile isolates from two Korean hospitals |
| Q39643157 | Multicenter evaluation of the Clostridium difficile TOX A/B TEST. |
| Q40938187 | Multilocus sequence typing analysis of human and animal Clostridium difficile isolates of various toxigenic types |
| Q31134424 | New types of toxin A-negative, toxin B-positive strains among Clostridium difficile isolates from Asia |
| Q36825457 | Novel molecular type of Clostridium difficile in neonatal pigs, Western Australia |
| Q37067252 | Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A. |
| Q73428793 | Performance of two rapid, single-use immunoassays for the detection of Clostridium difficile toxin A |
| Q39829292 | Positive regulation of Clostridium difficile toxins |
| Q39664770 | Prevalence and genetic characterization of toxin A variant strains of Clostridium difficile among adults and children with diarrhea in France |
| Q39457002 | Pseudomembranous colitis caused by a toxin A(-) B(+) strain of Clostridium difficile. |
| Q33602753 | Purification and characterization of alpha-toxin produced by Clostridium novyi type A |
| Q58405626 | Rapid detection of toxigenic Clostridium difficile from stool samples by a nested PCR of toxin B gene |
| Q35043878 | Spo0A differentially regulates toxin production in evolutionarily diverse strains of Clostridium difficile |
| Q27676848 | Structural Determinants of Clostridium difficile Toxin A Glucosyltransferase Activity |
| Q41596897 | Subinhibitory concentrations of LFF571 reduce toxin production by Clostridium difficile |
| Q34055302 | The anti-sigma factor TcdC modulates hypervirulence in an epidemic BI/NAP1/027 clinical isolate of Clostridium difficile |
| Q37954308 | The enterotoxicity of Clostridium difficile toxins |
| Q34006236 | The role of toxin A and toxin B in Clostridium difficile-associated disease: Past and present perspectives. |
| Q45099674 | The toxigenic element of Clostridium difficile strain VPI 10463. |
| Q33590965 | Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease |
| Q40668497 | Translocation of Clostridium difficile toxin B across polarized Caco-2 cell monolayers is enhanced by toxin A. |
| Q40532591 | What's a SNP between friends: The influence of single nucleotide polymorphisms on virulence and phenotypes of Clostridium difficile strain 630 and derivatives. |
Search more.